Masaki Miyazawa

ORCID: 0000-0003-0341-1123 · 4 papers in corpus
observational 2019
Journal of ovarian research ·doi:10.1186/s13048-019-0481-9

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Japan. OCCC has a more unfavorable clinical outcome due to a poor response to platinum-based chemotherapy, compared with sero…

2016
·doi:10.1016/j.ygyno.2016.04.092
other 2016
Oncology letters ·doi:10.3892/ol.2016.5082

Thymidine phosphorylase (TP) is structurally similar to platelet-derived endothelial cell growth factor, and it activates 5-fluorouracil (5-FU) prodrugs and also promotes angiogenesis. In the present study, the possibility of using TP expre…

diagnostic-accuracy 2015
Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.10.012

OBJECTIVE: While a certain fraction of endometriomas can develop de novo epithelial ovarian cancer (EOC) such as clear cell carcinoma (OCCC), there is currently no useful biomarker available for early detection of OCCC from endometriomas. T…